MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

Search

STAAR Surgical Co

Open

SectorGezondheidszorg

27.33 0.7

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

27.08

Max

27.47

Belangrijke statistieken

By Trading Economics

Inkomsten

37M

-17M

Verkoop

1.7M

44M

Winstmarge

-37.933

Werknemers

1,157

EBITDA

48M

-23M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

-3.13% downside

Dividenden

By Dow Jones

Volgende Winsten

29 okt 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

409M

1.3B

Vorige openingsprijs

26.63

Vorige sluitingsprijs

27.33

Nieuwssentiment

By Acuity

67%

33%

334 / 371 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

STAAR Surgical Co Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

2 sep 2025, 23:07 UTC

Acquisities, Fusies, Overnames

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

5 aug 2025, 10:10 UTC

Acquisities, Fusies, Overnames

Alcon to Buy Staar Surgical for $1.5 Billion

26 sep 2025, 21:56 UTC

Acquisities, Fusies, Overnames

Staar Surgical, Insight Enterprises, and More Stocks See Action From Activist Investors -- Barrons.com

22 sep 2025, 11:15 UTC

Acquisities, Fusies, Overnames

STAAR Surgical Announces Expiration of 'Window Shop' Period; No Competing Acquisition Proposals Received

16 sep 2025, 13:12 UTC

Acquisities, Fusies, Overnames

Staar Surgical Board Believes Value Provided by Alcon Merger Exceeds What STAAR Could Achieve on Standalone Basis in Foreseeable Future >STAA

16 sep 2025, 13:12 UTC

Acquisities, Fusies, Overnames

STAAR Board Unanimously Determined Proposed Merger With Alcon Is in Best Interests of Co, Stockholders >STAA

16 sep 2025, 13:11 UTC

Acquisities, Fusies, Overnames

Staar Surgical Will Hold Special Meeting of Stockholders on Oct 23 >STAA

16 sep 2025, 13:10 UTC

Acquisities, Fusies, Overnames

STAAR Surgical Bd of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders

8 aug 2025, 13:40 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Staar Surgical's Top Holder Questions Deal -- Market Talk

5 aug 2025, 05:07 UTC

Acquisities, Fusies, Overnames

Alcon Deal Puts STARR Equity Value at Approximately $1.5 Billion. >ALC.EB

5 aug 2025, 05:07 UTC

Acquisities, Fusies, Overnames

Alcon Will Purchase All Outstanding Shares of STAAR Common Stock for $28 Per Share in Cash >ALC.EB

5 aug 2025, 05:07 UTC

Acquisities, Fusies, Overnames

Alcon Deal Represents 51% Premium to Closing Price of STAAR Common Stock on Aug. 4 >ALC.EB

5 aug 2025, 05:07 UTC

Acquisities, Fusies, Overnames

Alcon Agrees to Acquire STAAR Surgical >ALC STAA

5 aug 2025, 05:01 UTC

Acquisities, Fusies, Overnames

Alcon Agrees To Acquire STAAR Surgical >ALC STAA

Peer Vergelijking

Prijswijziging

STAAR Surgical Co Prognose

Koersdoel

By TipRanks

-3.13% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 26.33 USD  -3.13%

Hoogste 28 USD

Laagste 18 USD

Gebaseerd op 8 Wall Street-analisten die 12-maands prijsdoelen bieden voor STAAR Surgical Co - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

8 ratings

0

Buy

8

Hold

0

Sell

Technische score

By Trading Central

18.604 / 20.07Steun & Weerstand

Korte Termijn

Strong Bullish Evidence

Gemiddeld Termijn

Very Strong Bullish Evidence

Lange Termijn

No Evidence

Sentiment

By Acuity

334 / 371 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
help-icon Live chat